![Beau Webber](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Beau Webber was the founder who held the position of Chief Technology Officer at B-MoGen Biotechnologies, Inc. from 2016 to 2019 and Chief Science Officer at Luminary Therapeutics, Inc. from 2019 to present.
| Unternehmen | Position | Beginn |
|---|---|---|
Luminary Therapeutics, Inc.
 Luminary Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops non-viral autologous cell therapies | Gründer | 01.01.2019 |
| Unternehmen | Position | Ende |
|---|---|---|
B-MoGen Biotechnologies, Inc.
 B-MoGen Biotechnologies, Inc. BiotechnologyHealth Technology Provides gene editing solutions for antibody validation, human disease research, gene transfer, and mitochondrial DNA editing | Gründer | 01.05.2019 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 2 |
|---|---|
B-MoGen Biotechnologies, Inc.
B-MoGen Biotechnologies, Inc. BiotechnologyHealth Technology Provides gene editing solutions for antibody validation, human disease research, gene transfer, and mitochondrial DNA editing | Health Technology |
Luminary Therapeutics, Inc.
Luminary Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops non-viral autologous cell therapies | Commercial Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
Wählen Sie MarketScreener 
